![Kevin Trapp](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin Trapp
Corporate Officer/Principal chez
DBV TECHNOLOGIES
Profil
Kevin Trapp is currently Chief Commercial Officer at DBV Technologies SA since 2025.
Formerly, Mr. Trapp was Senior Vice President-Portfolio & Access Strategy at Bristol Myers Squibb Co. from 2014 to 2016 and Chief Commercial Officer at DBV Technologies SA from 2018 to 2020.
Mr. Trapp completed undergraduate education at the University of Connecticut School of Business.
Postes actifs de Kevin Trapp
| Sociétés | Poste | Début |
|---|---|---|
| DBV TECHNOLOGIES | Corporate Officer/Principal | 03/11/2025 |
Anciens postes connus de Kevin Trapp
| Sociétés | Poste | Fin |
|---|---|---|
| DBV TECHNOLOGIES | Corporate Officer/Principal | 02/10/2020 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/06/2016 |
Formation de Kevin Trapp
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
71
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
DBV Technologies SA
 DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
University of Connecticut School of Business
 University of Connecticut School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
